Brief: Chemometec Raises 2026/27 EBITDA Guidance To DKK 335-360 Million
03/11/2026 09:23
BRIEF-Chemometec Raises 2026/27 EBITDA Guidance To DKK 335-360 Million Nov 3 (Reuters) - Chemometec A/S CHEMM.CO:
CHEMOMETEC Q1 REVENUE DKK 160 MILLION
RAISES 2026/27 REVENUE GUIDANCE TO DKK 570-605 MILLION
RAISES 2026/27 EBITDA GUIDANCE TO DKK 335-360 MILLION
Q1 2026/27 EBITDA DKK 100.30 MILLION, EBITDA MARGIN 63%
Source text: ID:nGNE75m5Rl
Further company coverage: CHEMM.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on ChemoMetec A/S
See all newsDenmark's Chemometec Q1 revenue rises 28% on instrument sales
Brief: Chemometec Q1 EBITDA DKK 100.3 Million
Denmark's ChemoMetec lifts FY outlook on strong instrument demand, lower costs
Brief: Chemometec Raises 2026/27 EBITDA Guidance To DKK 335-360 Million
Brief: Chemometec A/S Says Board Initiates Share Buy-Back Based On AGM Authorisation